Overview
Rui Shi practices in Chengdu, China. Mr. Shi is rated as an Experienced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Type 2 Diabetes (T2D), Restrictive Cardiomyopathy (RCM), Acute Lymphoblastic Leukemia (ALL), Bone Tumor, and Percutaneous Coronary Intervention (PCI).
His clinical research consists of co-authoring 133 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Restrictive Cardiomyopathy (RCM)
- Type 2 Diabetes (T2D)Mr. Shi isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Mr. Shi isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMr. Shi isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaMr. Shi isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Aortic RegurgitationMr. Shi isExperienced. Learn about Aortic Regurgitation.
- Atrial FibrillationMr. Shi isExperienced. Learn about Atrial Fibrillation.